Cormedix's total assets for Q2 2026 were $904.05M, an increase of 10.84% from the previous quarter. DE:19KA total liabilities were $443.22M for the fiscal quarter, a 17.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.